Department of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.
Department of Nutritional Sciences, University of Wisconsin-Madision, Madison, WI, United States.
Front Endocrinol (Lausanne). 2023 Aug 1;14:1223021. doi: 10.3389/fendo.2023.1223021. eCollection 2023.
Neuropilin 2 (NRP2) mediates the effects of class 3 semaphorins and vascular endothelial growth factor and is implicated in axonal guidance and angiogenesis. Moreover, NRP2 expression is suggested to be involved in the regulation of bone homeostasis. Indeed, osteoblasts and osteoclasts express NRP2 and male and female global knockout mice have a reduced bone mass accompanied by reduced osteoblast and increased osteoclast counts.
We first examined the effect of the calciotropic hormone 1,25-dihydroxyvitamin D [1,25(OH)D] on transcription in osteoblasts. We next generated mice with a conditional deletion of in the osteoblast cell lineage under control of the paired related homeobox 1 promoter and mice with a conditional knockdown in osteoclasts under control of the Lysozyme promoter. Mice were examined under basal conditions or after treatment with either the bone anabolic vitamin D analog WY 1048 or with 1,25(OH)D.
We show that expression is induced by 1,25(OH)D in osteoblasts and is associated with enrichment of the vitamin D receptor in an intronic region of the Nrp2 gene. In male mice, conditional deletion of in osteoblast precursors and mature osteoblasts recapitulated the bone phenotype of global knockout mice, with a reduced cortical cross-sectional tissue area and lower trabecular bone content. However, female mice with reduced osteoblastic expression display a reduced cross-sectional tissue area but have a normal trabecular bone mass. Treatment with the vitamin D analog WY 1048 (0.4 μg/kg/d, 14 days, ip) resulted in a similar increase in bone mass in both genotypes and genders. Deleting from the osteoclast lineage did not result in a bone phenotype, even though osteoclastogenesis of hematopoietic cells derived from mutant mice was significantly increased. Moreover, treatment with a high dose of 1,25(OH)D (0.5 μg/kg/d, 6 days, ip), to induce osteoclast-mediated bone resorption, resulted in a similar reduction in trabecular and cortical bone mass. In conclusion, osteoblastic expression is suggested to regulate bone homeostasis in a sex-specific manner.
神经纤毛蛋白 2(NRP2)介导了 III 类 semaphorin 和血管内皮生长因子的作用,参与了轴突导向和血管生成。此外,NRP2 的表达被认为参与了骨稳态的调节。事实上,成骨细胞和破骨细胞表达 NRP2,男性和女性的全局 NRP2 敲除小鼠的骨量减少,同时成骨细胞减少,破骨细胞增多。
我们首先研究了钙调节激素 1,25-二羟维生素 D [1,25(OH)D]对成骨细胞转录的影响。接下来,我们生成了成骨细胞谱系条件性缺失的小鼠,其在成对相关同源框 1 启动子的控制下,以及破骨细胞中条件性敲低的小鼠,其在溶酶体启动子的控制下。在基础条件下或用骨合成维生素 D 类似物 WY 1048 或 1,25(OH)D 处理后,对小鼠进行检查。
我们表明,1,25(OH)D 诱导成骨细胞中 NRP2 的表达,并且与维生素 D 受体在 Nrp2 基因的内含子区域的富集相关。在雄性小鼠中,成骨细胞前体和成骨细胞中条件性缺失 ,重现了全局 NRP2 敲除小鼠的骨表型,皮质横截面积组织减少,小梁骨含量降低。然而,成骨细胞中 NRP2 表达减少的雌性小鼠,其横截面积组织减少,但小梁骨量正常。用维生素 D 类似物 WY 1048(0.4μg/kg/d,14 天,ip)治疗,两种基因型和性别都导致骨量增加相似。从突变小鼠衍生的造血细胞中 从破骨细胞谱系中缺失不会导致骨表型,尽管破骨细胞生成显著增加。此外,用高剂量 1,25(OH)D(0.5μg/kg/d,6 天,ip)治疗,以诱导破骨细胞介导的骨吸收,导致小梁骨和皮质骨量相似减少。总之,成骨细胞中 NRP2 的表达以性别特异性的方式调节骨稳态。